Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization
Go back to Rani Therapeutics Appoints Jesper Høiland as Head of Strategy to Advance Corporate and Pipeline Prioritization| Asianada, Inc. (NASDAQ: ASND) | Delayed: 238.59 +10.59 (4.64%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.00 | 52 Week High | $21.79 | |||
| Open | $228.00 | 52 Week Low | $11.92 | |||
| Day High | $239.37 | P/E | N/A | |||
| Day Low | $222.82 | EPS | $-0.07 | |||
| Volume | 836,580 | |||||
| (NASDAQ: RANI) | Delayed: 0.76 -0.01 (1.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.77 | 52 Week High | $ | |||
| Open | $0.77 | 52 Week Low | $ | |||
| Day High | $0.80 | P/E | N/A | |||
| Day Low | $0.75 | EPS | $ | |||
| Volume | 413,660 | |||||
